Literature DB >> 27357278

HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Guangdi Li1, Erik De Clercq2.   

Abstract

The HIV genome encodes a small number of viral proteins (i.e., 16), invariably establishing cooperative associations among HIV proteins and between HIV and host proteins, to invade host cells and hijack their internal machineries. As a known example, the HIV envelope glycoprotein GP120 is closely associated with GP41 for viral entry. From a genome-wide perspective, a hypothesis can be worked out to determine whether 16 HIV proteins could develop 120 possible pairwise associations either by physical interactions or by functional associations mediated via HIV or host molecules. Here, we present the first systematic review of experimental evidence on HIV genome-wide protein associations using a large body of publications accumulated over the past 3 decades. Of 120 possible pairwise associations between 16 HIV proteins, at least 34 physical interactions and 17 functional associations have been identified. To achieve efficient viral replication and infection, HIV protein associations play essential roles (e.g., cleavage, inhibition, and activation) during the HIV life cycle. In either a dispensable or an indispensable manner, each HIV protein collaborates with another viral protein to accomplish specific activities that precisely take place at the proper stages of the HIV life cycle. In addition, HIV genome-wide protein associations have an impact on anti-HIV inhibitors due to the extensive cross talk between drug-inhibited proteins and other HIV proteins. Overall, this study presents for the first time a comprehensive overview of HIV genome-wide protein associations, highlighting meticulous collaborations between all viral proteins during the HIV life cycle.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27357278      PMCID: PMC4981665          DOI: 10.1128/MMBR.00065-15

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  623 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

Authors:  Ying Dang; Roderick W Davis; Ian A York; Yong-Hui Zheng
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.

Authors:  Ayşegül Özen; Kuan-Hung Lin; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-29       Impact factor: 11.205

Review 4.  The role of cellular factors in promoting HIV budding.

Authors:  Eric R Weiss; Heinrich Göttlinger
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

5.  A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.

Authors:  Laura Brandano; Mario Stevenson
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

6.  Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease.

Authors:  A A Bukovsky; T Dorfman; A Weimann; H G Göttlinger
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein.

Authors:  M A Handley; S Paddock; A Dall; A T Panganiban
Journal:  Virology       Date:  2001-12-20       Impact factor: 3.616

8.  Crystal structure of HIV-1 Tat complexed with human P-TEFb.

Authors:  Tahir H Tahirov; Nigar D Babayeva; Katayoun Varzavand; Jeffrey J Cooper; Stanley C Sedore; David H Price
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

9.  Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles.

Authors:  Charles M Trubey; Elena Chertova; Lori V Coren; Joanne M Hilburn; Catherine V Hixson; Kunio Nagashima; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41.

Authors:  Ashraf I Khasawneh; Annemarie Laumaea; David N Harrison; Anna K Bellamy-McIntyre; Heidi E Drummer; Pantelis Poumbourios
Journal:  Retrovirology       Date:  2013-04-23       Impact factor: 4.602

View more
  24 in total

1.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

2.  Assessing diversity in multiplex networks.

Authors:  Laura C Carpi; Tiago A Schieber; Panos M Pardalos; Gemma Marfany; Cristina Masoller; Albert Díaz-Guilera; Martín G Ravetti
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

3.  Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.

Authors:  Sizhu Duan; Xin Yu; Chu Wang; Lina Meng; Yanxin Gai; Yan Zhou; Tiejun Gu; Bin Yu; Jiaxin Wu; Xianghui Yu
Journal:  J Virol       Date:  2022-08-11       Impact factor: 6.549

4.  Epidemiology and Clinical Outcomes of HIV Infection in South-Central China: A Retrospective Study From 2003 to 2018.

Authors:  Tingting Yue; Pan Zhang; Yuantao Hao; Jianmei He; Jun Zheng; Erik De Clercq; Guangdi Li; Yaxiong Huang; Fang Zheng
Journal:  Front Public Health       Date:  2022-06-09

5.  Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.

Authors:  Samantha Climaco-Arvizu; Víctor Flores-López; Carolina González-Torres; Francisco Javier Gaytán-Cervantes; María Concepción Hernández-García; Paola Berenice Zárate-Segura; Monserrat Chávez-Torres; Emiliano Tesoro-Cruz; Sandra María Pinto-Cardoso; Vilma Carolina Bekker-Méndez
Journal:  BMC Infect Dis       Date:  2022-05-10       Impact factor: 3.667

Review 6.  Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders.

Authors:  Lijun Zhang; Xiaofang Jia; Jun-O Jin; Hongzhou Lu; Zhimi Tan
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-04-06       Impact factor: 7.691

Review 7.  The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs.

Authors:  Giovanni Barillari
Journal:  Front Oncol       Date:  2020-05-21       Impact factor: 6.244

8.  B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs.

Authors:  Kimia Kardani; Azam Bolhassani; Elnaz Agi; Atieh Hashemi
Journal:  Biotechnol Lett       Date:  2020-05-25       Impact factor: 2.461

Review 9.  Tetraspanins, Another Piece in the HIV-1 Replication Puzzle.

Authors:  Henar Suárez; Vera Rocha-Perugini; Susana Álvarez; María Yáñez-Mó
Journal:  Front Immunol       Date:  2018-08-03       Impact factor: 7.561

10.  Specific reverse transcriptase slippage at the HIV ribosomal frameshift sequence: potential implications for modulation of GagPol synthesis.

Authors:  Christophe Penno; Romika Kumari; Pavel V Baranov; Douwe van Sinderen; John F Atkins
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.